Cardiogen 20mg × 10 vials

A short bioregulatory peptide studied for cardiovascular system research, myocardial tissue regulation, fibroblast activity, cellular proliferation, and apoptosis-related pathways.

Product Overview

Compound: Cardiogen
Strength: 20 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 20 mg
BAC water: 2 mL
Amount per unit: 100 mcg per unit

Research Dose

Protocol dependent.

Notes

Cardiogen is described in published research as a short tetrapeptide with the amino acid sequence Ala-Glu-Asp-Arg / AEDR. It has been studied in relation to myocardial tissue, cellular proliferation, and apoptosis-related mechanisms.

No standard consumer dosing protocol should be assumed. Use only within appropriate research or professional guidance frameworks.

Disclaimer

This product is intended for research and informational purposes only.